Australian Genetics of Depression Study

Clinical depression affects almost one in five people during their lifetime and the World Health Organisation (WHO) predicts that by 2020 clinical depression will impost the second highest burden of any disease in Australia and other advanced countries.

The Australian Genetics of Depression Study is part of an international study created to further understanding about the genetic drivers behind clinical depression, and the genetic factors that influence the effectiveness of various clinical depression treatments.

More than 20,000 Australian adults aged 18 and above who have been treated for clinical depression are being recruited for the study.

For more information including information on how to participate in the study click here.

Let us keep you up-to-date

Subscribe to the NFPAS email newsletter to receive not for profit industry news and special updates.